Skip to content

IEMbase 0572: UCP2-related hyperinsulinism

Scope

Field Value
IEMbase ID 572
Nosology 24.1.08.02
Gene UCP2
External IDs OMIM:601693; ORPHA:276556
Generated mapping UNMAPPED; best candidate Pyruvate_Dehydrogenase_Deficiency.yaml
Candidate DisMech targets Congenital_Isolated_Hyperinsulinism.yaml as broad context only
Review date 2026-07-07

IEMbase phenotype signal

IEMbase represents UCP2-related uncoupling protein 2 deficiency, abbreviated UCP2-HI. The record is autosomal dominant, idiopathic subtype, of unknown treatability, and has no treatment rows.

Biochemical rows include decreased free fatty acids during hypoglycemia, decreased ketones during hypoglycemia, low plasma glucose, and normal-to-high insulin during hypoglycemia. Characteristic rows include hyperinsulinism and hypoketotic hypoglycemia.

DisMech phenotype coverage

Congenital_Isolated_Hyperinsulinism.yaml includes broad CHI mechanisms and an evidence snippet naming UCP2 among known CHI genes, but it does not appear to model a UCP2-HI subtype or UCP2-specific mitochondrial uncoupling/beta-cell metabolic mechanism. The generated Pyruvate_Dehydrogenase_Deficiency.yaml candidate is a false positive and does not match the UCP2-HI disease scope.

Concordance and completeness

Judgement: broad CHI context only; exact UCP2-related hyperinsulinism coverage remains a local gap.

IEMbase overlaps with the local CHI entry on hyperinsulinism, hypoketotic hypoglycemia, low plasma glucose, suppressed free fatty acids, and suppressed ketones. The gene-specific UCP2 mechanism and subtype are missing.

Curation actions

  • Reject Pyruvate_Dehydrogenase_Deficiency.yaml as an exact mapping.
  • Add UCP2-HI to the congenital hyperinsulinism backlog.
  • Preserve IEMbase free-fatty-acid, ketone, glucose, insulin, and UCP2-HI alias prompts for future source review.